Insider trades

Robin Howard W., CEO of Nektar Therapeutics NKTR, has filed 0 purchases and 32 sales on the open market. Over the past 12 months that comes to a net sale of $1.4M. The latest trade was on 06/17.

Robin Howard W.

President & CEO
First filing
23/02/17
Trades
41 trades
Buys / sales
0 / 32
12-month net buying
−$1.4M
Last trade
06/17

Trading activity

Transactions

Trade type
NKTR
Open-market sale10b5-1 plan06/16–06/1706/1820,000 sh4 trades$60.75avg.$1,215,055.78−26.7%
Open-market sale05/1905/21444 sh$65.51$29,086.44−0.6%
Open-market sale02/1802/20423 sh$73.00$30,879−0.6%
Open-market sale25/11/2525/11/252,207 sh$54.28$119,795.96−3.9%
NKTR
Open-market sale10b5-1 plan25/09/0925/09/116,666 sh4 trades$46.69avg.$311,214.24−11.9%
NKTR
Open-market sale10b5-1 plan25/09/04–25/09/0525/09/0811,832 sh7 trades$36.42avg.$430,958.59−17.4%
Open-market sale10b5-1 plan25/09/0225/09/041,500 sh$30.16$45,240−2.2%
Open-market sale25/08/1925/08/211,573 sh$26.59$41,826.07−2.2%
Open-market sale25/05/1925/05/2123,208 sh$0.67$15,549.36−2.1%
Open-market sale25/02/1925/02/2123,774 sh$1.01$24,011.74−2.1%
NKTR
Open-market sale24/12/17–24/12/1824/12/19132,030 sh2 trades$1.00avg.$131,649.6−10.6%
Open-market sale24/11/1924/11/2016,278 sh$1.01$16,440.78−1.9%
Open-market sale24/08/1924/08/2014,881 sh$1.28$19,047.68−1.7%
Open-market sale24/05/1724/05/2016,650 sh$1.75$29,137.5−1.9%
Open-market sale24/02/2024/02/2220,033 sh$0.68$13,622.44−2.2%
Open-market sale23/11/1723/11/2019,877 sh$0.49$9,739.73−2.2%
Open-market sale23/08/1623/08/1719,998 sh$0.78$15,598.44−2.1%
Open-market sale23/05/1623/05/1720,361 sh$0.72$14,659.92−2.1%
Open-market sale23/02/1623/02/1719,635 sh$3.00$58,905−2.0%